Cargando…
Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models
Discovery of new drugs for cancer treatment is an expensive and time-consuming process and the percentage of drugs reaching the clinic remains quite low. Drug repositioning refers to the identification and development of new uses for existing drugs and represents an alternative drug development stra...
Autores principales: | Rico, María, Baglioni, María, Bondarenko, Maryna, Laluce, Nahuel Cesatti, Rozados, Viviana, Nicolas, André, Carré, Manon, Scharovsky, O. Graciela, Márquez, Mauricio Menacho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356849/ https://www.ncbi.nlm.nih.gov/pubmed/27926515 http://dx.doi.org/10.18632/oncotarget.13760 |
Ejemplares similares
-
Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: Anselmino, L. E., et al.
Publicado: (2021) -
Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
por: Anselmino, L. E., et al.
Publicado: (2023) -
Synuclein Proteins in Cancer Development and Progression
por: Zanotti, Lucía C., et al.
Publicado: (2023) -
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017) -
Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
por: Mainetti, Leandro E., et al.
Publicado: (2020)